Pamidronate Disodium (APP Pharmaceuticals, LLC)


Welcome to the PulseAid listing for the Pamidronate Disodium drug offered from APP Pharmaceuticals, LLC. This Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: APP Pharmaceuticals, LLC
NON-PROPRIETARY NAME: PAMIDRONATE DISODIUM
SUBSTANCE NAME: PAMIDRONATE DISODIUM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2002-05-19
END MARKETING DATE: 0000-00-00


Pamidronate Disodium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPamidronate Disodium from APP Pharmaceuticals, LLC
LABELER NAME: APP Pharmaceuticals, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 3(mg/mL)
START MARKETING DATE: 2002-05-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63323-734_80ed4c20-1e43-4fe2-bfd9-64652ba75471
PRODUCT NDC: 63323-734
APPLICATION NUMBER: ANDA076207

Other PAMIDRONATE DISODIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
American Regent, Inc.Pamidronate Disodium
APP Pharmaceuticals, LLCPamidronate Disodium
Areva Pharmaceuticals Inc.Pamidronate Disodium
Hospira, Inc.Pamidronate Disodium
Mylan Institutional LLCPamidronate Disodium
Pfizer Laboratories Div Pfizer IncPamidronate Disodium
Teva Parenteral Medicines, Inc.Pamidronate Disodium